PhD Thesis Loe Hui Li @ Felicia Celeste Loe 2010 (HT050567A) ________________________________________________________________________________________ BIBLIOGRAPHY Orthopaedic Surgeons. 1999;Propagation and 1. Pittenger MF, Mackay AM, Beck SC, et al. 1999;Multilineage potential of adult human mesenchymal stem cells. Science (5411):143-147. 2. Friedenstein AJ, Petrakova KV, Kurolesova AI, et al. 1968;Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation (2):230-247. 3. Friedenstein AJ, Chailakhjan RK, Lalykina KS. 1970;The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet (4):393-403. 4. Friedenstein AJ, Deriglasova UF, Kulagina NN, et al. 1974;Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol (2):83-92. 5. Haynesworth S, Goldberg V, Caplan A, et al. Diminution of the number of Mesenchymal stem cells as a cause for skeletal aging Y, editors. American Academy of 1994. 79-87 p. 6. Subbanna PKT. 2007;Mesenchymal stem cells for treating GVHD: in-vivo fate and optimal dose. Med Hypotheses (2):469-470. 7. Simonsen JL, Rosada C, Serakinci N, et al. 2002; Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol (6):592-596. 8. Banfi A, Muraglia A, Dozin B, et al. 2000;Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. Exp Hematol (6):707-715. 9. Hayflick L. 1965;The limited in vitro lifetime of human diploid cell strains. Exp Cell Res :614-636. 10. Stenderup K, Justesen J, Clausen C, et al. 2003;Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone (6):919-926. 11. DiGirolamo C, Stokes D, Colter D. senescence of human marrow stromal cells in culture: A simple colonyforming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol :275-281. 12. Baksh D, Song L, Tuan RS. 2004;Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med (3):301-316. 13. Rubio D, GarciaCastro J, Martín MC, et al. 2005;Spontaneous human adult stem cell transformation. Cancer Res (8):3035-3039. 14. Fuchs E, Tumbar T, Guasch G. 2004;Socializing with the neighbors: stem cells and their niche. Cell (6):769778. 15. Morrison SJ, Spradling AC. 2008;Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell (4):598-611. 16. Campbell FR. 1987;An electron microscopic study of microfibrils of bone marrow. Scanning Microsc (4):1711-1714. i PhD Thesis Loe Hui Li @ Felicia Celeste Loe 2010 (HT050567A) ________________________________________________________________________________________ 17. Hynes RO. 1987;Integrins: a family of cell surface receptors. Cell (4):549-554. 18. Damsky CH, Werb Z. 1992;Signal transduction by integrin receptors for extracellular matrix: cooperative processing of extracellular information. Curr Opin Cell Biol (5):772781. 19. Farias E, Lu M, Li X, et al. 2005;Integrin alpha8beta1-fibronectin interactions promote cell survival via PI3 kinase pathway. Biochem Biophys Res Commun (1):305-311. 20. Cowles EA, Brailey LL, Gronowicz GA. 2000;Integrin-mediated signaling regulates AP-1 transcription factors and proliferation in osteoblasts. J Biomed Mater Res (4):725-737. 21. Taipale J, Keski-Oja J. 1997;Growth factors in the extracellular matrix. FASEB J (1):51-59. 22. Rifkin DB, Mazzieri R, Munger JS, et al. 1999;Proteolytic control of growth factor availability. APMIS (1):8085. 23. Hildebrand A, Romarís M, Rasmussen LM, et al. 1994;Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J :527534. 24. Iozzo RV. 1999;The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins. J Biol Chem (27):18843-18846. 25. Fogh-Andersen N, Altura BM, Altura BT, et al. 1995;Composition of interstitial fluid. Clin Chem (10):1522-1525. 26. Ellis RJ. 2001;Macromolecular crowding: obvious but underappreciated. Trends Biochem Sci (10):597-604. 27. Ellis RJ. 2001;Macromolecular crowding: an important but neglected aspect of the intracellular environment. Curr Opin Struct Biol (1):114-119. 28. Zimmerman SB, Minton AP. 1993;Macromolecular crowding: biochemical, biophysical, and physiological consequences. Annu Rev Biophys Biomol Struct :2765. 29. Chebotareva NA, Kurganov BI, Livanova NB. 2004;Biochemical effects of molecular crowding. Biochemistry (Mosc) (11):1239-1251. 30. Minton AP. 2006;How can biochemical reactions within cells differ from those in test tubes? J Cell Sci (Pt 14):2863-2869. 31. Schofield R. 1978;The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells (12):7-25. 32. Moore KA, Lemischka IR. 2006;Stem cells and their niches. Science (5769):1880-1885. 33. Lemischka IR, Moore KA. 2003;Stem cells: interactive niches. Nature (6960):778-779. 34. Gregory CA, Ylostalo J, Prockop DJ. 2005;Adult bone marrow stem/progenitor cells (MSCs) are preconditioned by microenvironmental "niches" in culture: a twostage hypothesis for regulation of MSC fate. Sci STKE (294):pe37. 35. Lareu RR, Subramhanya KH, Peng Y, et al. 2007;Collagen matrix deposition is dramatically enhanced in vitro when crowded with ii PhD Thesis Loe Hui Li @ Felicia Celeste Loe 2010 (HT050567A) ________________________________________________________________________________________ charged macromolecules: the biological relevance of the excluded volume effect. FEBS Lett (14):2709-2714. 36. Lareu RR, Arsianti I, Subramhanya HK, et al. 2007;In vitro enhancement of collagen matrix formation and crosslinking for applications in tissue engineering: a preliminary study. Tissue Eng (2):385391. 37. Qian L, Saltzman WM. 2004;Improving the expansion and neuronal differentiation of mesenchymal stem cells through culture surface modification. Biomaterials (7-8):1331-1337. 38. Koyama H, Raines EW, Bornfeldt KE, et al. 1996;Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell (6):1069-1078. 39. Mauney JR, Kaplan DL, Volloch V. 2004;Matrix-mediated retention of osteogenic differentiation potential by human adult bone marrow stromal cells during ex vivo expansion. Biomaterials (16):32333243. 40. van der Flier A, Sonnenberg A. 2001;Function and interactions of integrins. Cell Tissue Res (3):285-298. 41. Mould AP, Askari JA, Aota SI, et al. 1997;Defining the topology of integrin alpha5beta1-fibronectin interactions using inhibitory anti-alpha5 and anti-beta1 monoclonal antibodies. Evidence that the synergy sequence of fibronectin is recognized by the amino-terminal repeats of the alpha5 subunit. J Biol Chem (28):17283-17292. 42. Cukierman E, Pankov R, Stevens DR, et al. 2001;Taking cell-matrix adhesions to the third dimension. Science (5547):1708-1712. 43. Pierschbacher M, Hayman C, Ruoslahti E. 1984;nd Variants of the cell recognition site of fibronectin that retain attachment-promoting activity. Proc Natl Acad Sci USA :1224-1227. 44. Danilov YN, Juliano RL. 1989;(Arg-Gly-Asp)nalbumin conjugates as a model substratum for integrin-mediated cell adhesion. Exp Cell Res (1):186-196. 45. Flaim C, Chien S, Bhatia S. 1995;An extracellular matrix microarray for probing cellular differentiation. Nature Methods FoghAndersen Composition of Interstitial Fluid Clin Chem 1522 (10):119-125. 46. Engler AJ, Sen S, Sweeney HL, et al. 2006;Matrix elasticity directs stem cell lineage specification. Cell (4):677689. 47. Bader A, Knop E, Kern A, et al. 1996;3-D coculture of hepatic sinusoidal cells with primary hepatocytesdesign of an organotypical model. Exp Cell Res (1):223-233. 48. Kleinman HK, McGarvey ML, Liotta LA, et al. 1982;Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry (24):6188-6193. 49. Ahmed TAE, Dare EV, Hincke M. 2008;Fibrin: a versatile scaffold for tissue engineering applications. Tissue engineering. Part B, Reviews (2):199-215. 50. Ito K, Yamada Y, Naiki T, et al. 2006;Simultaneous implant placement and bone regeneration around iii PhD Thesis Loe Hui Li @ Felicia Celeste Loe 2010 (HT050567A) ________________________________________________________________________________________ dental implants using tissue-engineered bone with fibrin glue, mesenchymal stem cells and platelet-rich plasma. Clin Oral Implants Res (5):579-586. 51. Awad HA, Butler DL, Harris MT, et al. 2000;In vitro characterization of mesenchymal stem cellseeded collagen scaffolds for tendon repair: effects of initial seeding density on contraction kinetics. J Biomed Mater Res (2):233240. 52. Schmeichel KL, Bissell MJ. 2003;Modeling tissue-specific signaling and organ function in three dimensions. J Cell Sci (Pt 12):2377-2388. 53. Bissell MJ, BarcellosHoff MH. 1987;The influence of extracellular matrix on gene expression: is structure the message? J Cell Sci Suppl :327-343. 54. Bissell MJ, Aggeler J. 1987;Dynamic reciprocity: how extracellular matrix and hormones direct gene expression? Prog Clin Biol Res :251-262. 55. Lutolf MP, Hubbell JA. 2005;Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol (1):47-55. 56. Cushing MC, Anseth KS. 2007;Materials science. Hydrogel cell cultures. Science (5828):1133-1134. 61. Grünert M, Dombrowski C, Sadasivam M, et al. 2007;Isolation of a native osteoblast matrix with a specific affinity for BMP2. J Mol Histol (5):393-404. 57. Lutolf MP. 2009;Integration column: artificial ECM: expanding the cell biology toolbox in 3D. Integrative biology : quantitative biosciences from nano to macro (3):235-241. 62. van den Bos C, Mosca JD, Winkles J, et al. 1997;Human mesenchymal stem cells respond to fibroblast growth factors. Hum Cell (1):45-50. 58. Zhou L, Lai ZT, Lu MK, et al. 2008;Expression and hydroxylamine cleavage of thymosin alpha concatemer. Journal of biomedicine & biotechnology :736060. 63. Hanada K, Dennis JE, Caplan AI. 1997;Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J Bone Miner Res (10):16061614. 59. Matsubara T, Tsutsumi S, Pan H, et al. 2004;A new technique to expand human mesenchymal stem cells using basement membrane extracellular matrix. Biochem Biophys Res Commun (3):503-508. 60. Chen XD, Dusevich V, Feng JQ, et al. 2007;Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts. J Bone Miner Res (12):1943-1956. 64. Akino K, Mineta T, Fukui M, et al. 2003;Bone morphogenetic protein-2 regulates proliferation of human mesenchymal stem cells. Wound Repair Regen (5):354-360. 65. Xiao Z, Zhang W, Yang Y, et al. 2008;Singlemolecule diffusion study of activated EGFR implicates its endocytic pathway. Biochem Biophys Res Commun (2):730-734. 66. Friedl A, Chang Z, iv PhD Thesis Loe Hui Li @ Felicia Celeste Loe 2010 (HT050567A) ________________________________________________________________________________________ Tierney A, et al. 1997;Differential binding of fibroblast growth factor-2 and -7 to basement membrane heparan sulfate: comparison of normal and abnormal human tissues. Am J Pathol (4):1443-1455. 67. Yayon A, Klagsbrun M, Esko JD, et al. 1991;Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell (4):841-848. 68. Dombrowski C, Song SJ, Chuan P, et al. 2009;Heparan sulfate mediates the proliferation and differentiation of rat mesenchymal stem cells. Stem Cells Dev (4):661-670. 69. Edlund U, Dånmark S, Albertsson AC. 2008;A strategy for the covalent functionalization of resorbable polymers with heparin and osteoinductive growth factor. Biomacromolecules (3):901-905. 70. Benoit DSW, Durney AR, Anseth KS. 2007;The effect of heparinfunctionalized PEG hydrogels on threedimensional human mesenchymal stem cell osteogenic differentiation. Biomaterials (1):66-77. 71. Serakinci N, Guldberg P, Burns JS, et al. 2004;Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene (29):5095-5098. 72. Minton AP. 2001;The influence of macromolecular crowding and macromolecular confinement on biochemical reactions in physiological media. J Biol Chem (14):10577-10580. 73. Minton AP. 1993;Macromolecular crowding and molecular recognition. J Mol Recognit (4):211-214. 74. Grisendi G, Annerén C, Cafarelli L, et al. 2010;GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion. Cytotherapy 75. Du F, Zhou Z, Mo ZY, et al. 2006;Mixed macromolecular crowding accelerates the refolding of rabbit muscle creatine kinase: implications for protein folding in physiological environments. J Mol Biol (3):469-482. 76. Harve Vigneshwar Rajagopalan R, KS, R, et al. 2008;Macromolecular crowding in vitro as means of emulating cellular interiors: when less might be more. Proc Natl Acad Sci U S A (51):E119; author reply E120. 77. Batra J, Xu K, Zhou HX. 2009;Nonadditive effects of mixed crowding on protein stability. Proteins (1):133-138. 78. Harve KS, Lareu R, Rajagopalan R, et al. 2010;Understanding how the crowded interior of cells stabilizes DNA/DNA and DNA/RNA hybrids-in silico predictions and in vitro evidence. Nucleic Acids Res (1):172-181. 79. Chen CZC, Peng YX, Wang ZB, et al. 2009;The Scar-in-a-Jar: studying potential antifibrotic compounds from the epigenetic to extracellular level in a single well. Br J Pharmacol (5):1196-1209. 80. Harve K, Lareu R, Rajagopalan R, et al. 2006;Macromolecular Crowding in Biological Systems: Dynamic Light Scattering (DLS) to quantify the Excluded Volume Effect (EVE). Biophysical Reviews and Letters-:. (3):317-325. 81. Prockop DJ, Sieron v PhD Thesis Loe Hui Li @ Felicia Celeste Loe 2010 (HT050567A) ________________________________________________________________________________________ AL, Li SW. 1998;Procollagen Nproteinase and procollagen C-proteinase. Two unusual metalloproteinases that are essential for procollagen processing probably have important roles in development and cell signaling. Matrix Biol (7):399-408. defects by fibroblasts cultured in the presence of dextran sulphate. Biochem J (3):573-577. 82. Lilla J, Stickens D, Werb Z. 2002;Metalloproteases and adipogenesis: a weighty subject. Am J Pathol (5):1551-1554. 88. Mauney JR, Volloch V, Kaplan DL. 2005;Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion. Biomaterials (31):61676175. 83. Mariman ECM, Wang P. 2010;Adipocyte extracellular matrix composition, dynamics and role in obesity. Cell Mol Life Sci (8):1277-1292. 84. Auger FA, Berthod F, Moulin V, et al. 2004;Tissue-engineered skin substitutes: from in vitro constructs to in vivo applications. Biotechnol Appl Biochem (Pt 3):263275. 85. Bateman JF, Cole WG, Pillow JJ, et al. 1986;Induction of procollagen processing in fibroblast cultures by neutral polymers. J Biol Chem (9):4198-4203. 86. Bateman JF, Golub SB. 1990;Assessment of procollagen processing 87. Noble BS, Dean V, Loveridge N, et al. 1995;Dextran sulfate promotes the rapid aggregation of porcine bone-marrow stromal cells. Bone (4):375-382. 89. Bissell MJ, Hall HG, Parry G. 1982;How does the extracellular matrix direct gene expression? J Theor Biol (1):31-68. 90. Nelson CM, Bissell MJ. 2006;Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu Rev Cell Dev Biol :287-309. 91. Bissell MJ, Inman J. 2008;Reprogramming stem cells is a microenvironmental task. Proc Natl Acad Sci U S A (41):15637-15638. 92. Xu R, Boudreau A, Bissell MJ. 2009;Tissue architecture and function: dynamic reciprocity via extra- and intra-cellular matrices. Cancer Metastasis Rev (1-2):167-176. 93. Maxwell CA, McCarthy J, Turley E. 2008;Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions? J Cell Sci (Pt 7):925-932. 94. Sanderson RD, Yang Y, Suva LJ, et al. 2004;Heparan sulfate proteoglycans and heparanase--partners in osteolytic tumor growth and metastasis. Matrix Biol (6):341-352. 95. Sottile J, Hocking DC. 2002;Fibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cellmatrix adhesions. Mol Biol Cell (10):3546-3559. 96. Keely PJ, Wu JE, Santoro SA. 1995;The spatial and temporal expression of the alpha beta integrin and its ligands, collagen I, collagen IV, and laminin, suggest important roles in mouse mammary morphogenesis. Differentiation (1):1-13. vi PhD Thesis Loe Hui Li @ Felicia Celeste Loe 2010 (HT050567A) ________________________________________________________________________________________ 97. Talhouk RS, Chin JR, Unemori EN, et al. 1991;Proteinases of the mammary gland: developmental regulation in vivo and vectorial secretion in culture. Development (2):439-449. 98. Taddei I, Deugnier MA, Faraldo MM, et al. 2008;Beta1 integrin deletion from the basal compartment of the mammary epithelium affects stem cells. Nat Cell Biol (6):716-722. 99. Woodward TL, Mienaltowski AS, Modi RR, et al. 2001;Fibronectin and the alpha(5)beta(1) integrin are under developmental and ovarian steroid regulation in the normal mouse mammary gland. Endocrinology (7):32143222. 100. Salasznyk RM, Klees RF, Williams WA, et al. 2007;Focal adhesion kinase signaling pathways regulate the osteogenic differentiation of human mesenchymal stem cells. Exp Cell Res (1):22-37. 101. Salasznyk RM, Klees RF, Boskey A, et al. 2007;Activation of FAK is necessary for the osteogenic differentiation of human mesenchymal stem cells on laminin-5. J Cell Biochem (2):499-514. 102. Lozito TP, Kuo CK, Taboas JM, et al. 2009;Human mesenchymal stem cells express vascular cell phenotypes upon interaction with endothelial cell matrix. J Cell Biochem (4):714-722. 103. Lozito TP, Taboas JM, Kuo CK, et al. 2009;Mesenchymal stem cell modification of endothelial matrix regulates their vascular differentiation. J Cell Biochem (4):706-713. 104. Kuhn NZ, Tuan RS. 2010;Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis. J Cell Physiol (2):268-277. 105. Tsai MS, Hwang SM, Chen KD, et al. 2007;Functional network analysis of the transcriptomes of mesenchymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow. Stem Cells (10):2511-2523. 106. Rosen ED, Spiegelman BM. 2000;Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol :145-171. 107. McBeath R, Pirone DM, Nelson CM, et al. 2004;Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell (4):483-495. 108. Gregoire FM, Smas CM, Sul HS. 1998;Understanding adipocyte differentiation. Physiol Rev (3):783-809. 109. Alexander CM, Selvarajan S, Mudgett J, et al. 2001;Stromelysin-1 regulates adipogenesis during mammary gland involution. J Cell Biol (4):693-703. 110. Zizola CF, Julianelli V, Bertolesi G, et al. 2007;Role of versican and hyaluronan in the differentiation of 3T3-L1 cells into preadipocytes and mature adipocytes. Matrix Biol (6):419-430. 111. Gimble JM, Morgan C, Kelly K, et al. 1995;Bone morphogenetic proteins inhibit adipocyte differentiation by bone marrow stromal cells. J Cell Biochem (3):393-402. 112. Cawthon RM. 2002;Telomere measurement by quantitative PCR. Nucleic Acids Res (10):e47. 113. Boulay JL, Reuter J, vii PhD Thesis Loe Hui Li @ Felicia Celeste Loe 2010 (HT050567A) ________________________________________________________________________________________ Ritschard R, et al. 1999;Gene dosage by quantitative real-time PCR. Biotechniques (2):22830, 232. 114. Minguell JJ, Erices A, Conget P. 2001;Mesenchymal stem cells. Exp Biol Med (Maywood) (6):507-520. 115. Aratani Y, Kitagawa Y. 1988;Enhanced synthesis and secretion of type IV collagen and entactin during adipose conversion of 3T3-L1 cells and production of unorthodox laminin complex. J Biol Chem (31):16163-16169. 116. Mitsi M, ForstenWilliams K, Gopalakrishnan M, et al. 2008;A catalytic role of heparin within the extracellular matrix. J Biol Chem (50):34796-34807. 117. Wilson EL, Rifkin DB, Kelly F, et al. 1991;Basic fibroblast growth factor stimulates myelopoiesis in long-term human bone marrow cultures. Blood (5):954-960. 118. Tsutsumi S, Shimazu A, Miyazaki K, et al. 2001;Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun (2):413-419. 119. Sasada R, Seno M, Watanabe T, et al. 1991;Expression of modified bFGF cDNAs in mammalian cells. Ann N Y Acad Sci :149-160. 120. Kolf CM, Cho E, Tuan RS. 2007;Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther (1):204. 121. Owen M, Peck W. 1985;Lineage of osteogenic cells and their relationship to the stromal system. In ed Bone and MineralAmsterdam Elsevier pp :1-25. 122. Owen M. 1988;Marrow stromal stem cells. J Cell Sci Suppl :63-76. 123. Beresford JN. 1989;Osteogenic stem cells and the stromal system of bone and marrow. Clin Orthop Relat Res (240):270-280. 124. Caplan AI. 1991;Mesenchymal stem cells. J Orthop Res (5):641650. 125. Caplan A, Fink D, Goto T, et al. 1993;Mesenchymal stem cells and tissue repair. In ed The Anterior Cruciate Ligament Current and Future Concepts New York Raven Press Ltd pp :405-417. 126. Wakitani S, Saito T, Caplan AI. 1995;Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5azacytidine. Muscle Nerve (12):1417-1426. 127. Dennis JE, Caplan AI. 1996;Differentiation potential of conditionally immortalized mesenchymal progenitor cells from adult marrow of a H-2Kb-tsA58 transgenic mouse. J Cell Physiol (3):523-538. 128. Mackay AM, Beck SC, Murphy JM, et al. 1998;Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng (4):415-428. 129. Beresford JN, Graves SE, Smoothy CA. 1993;Formation of mineralized nodules by bone derived cells in vitro: a model of bone formation? Am J Med Genet (2):163-178. 130. Greenspan P, Mayer EP, Fowler SD. 1985;Nile red: a selective fluorescent stain for intracellular lipid droplets. J Cell Biol viii PhD Thesis Loe Hui Li @ Felicia Celeste Loe 2010 (HT050567A) ________________________________________________________________________________________ (3):965-973. 131. Hamilton R, Campbell FR. 1991;Immunochemical localization of extracellular materials in bone marrow of rats. Anat Rec (2):218-224. 132. Wallace DG, Rosenblatt J. 2003;Collagen gel systems for sustained delivery and tissue engineering. Adv Drug Deliv Rev (12):16311649. 133. Globus RK, Doty SB, Lull JC, et al. 1998;Fibronectin is a survival factor for differentiated osteoblasts. J Cell Sci :1385-1393. 134. Carvalho RS, Kostenuik PJ, Salih E, et al. 2003;Selective adhesion of osteoblastic cells to different integrin ligands induces osteopontin gene expression. Matrix Biol (3):241-249. 135. Spiegelman BM, Ginty CA. 1983;Fibronectin modulation of cell shape and lipogenic gene expression in 3T3adipocytes. Cell (3 Pt 2):657-666. basal lamina molecules expression in human subcutaneous white adipose tissue. Eur J Histochem (3):183-188. 137. Kapuscinski J. 1995;DAPI: a DNAspecific fluorescent probe. Biotech Histochem (5):220233. 138. Cooper JA. 1987;Effects of cytochalasin and phalloidin on actin. J Cell Biol (4):1473-1478. 139. Quéméneur E, Guthapfel R, Gueguen P. 1994;A major phosphoprotein of the endoplasmic reticulum is protein disulfide isomerase. J Biol Chem (8):5485-5488. 140. Bouwman F, Renes J, Mariman E. 2004;A combination of protein profiling and isotopomer analysis using matrixassisted laser desorption/ionizationtime of flight mass spectrometry reveals an active metabolism of the extracellular matrix of 3T3-L1 adipocytes. Proteomics (12):3855-3863. 136. Pierleoni C, Verdenelli F, Castellucci M, et al. 1998;Fibronectins and ix . 1997;Defining the topology of integrin alpha5beta1-fibronectin interactions using inhibitory anti-alpha5 and anti-beta1 monoclonal antibodies. Evidence that the synergy sequence of fibronectin. PJ, Wu JE, Santoro SA. 1995 ;The spatial and temporal expression of the alpha 2 beta 1 integrin and its ligands, collagen I, collagen IV, and laminin, suggest important roles in mouse mammary. formation and crosslinking for applications in tissue engineering: a preliminary study. Tissue Eng (2):385- 391. 37. Qian L, Saltzman WM. 2004;Improving the expansion and neuronal differentiation